These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11229845)

  • 1. Use of cytokines in human immunodeficiency virus-infected patients: colony-stimulating factors, erythropoietin, and interleukin-2.
    Armstrong WS; Kazanjian P
    Clin Infect Dis; 2001 Mar; 32(5):766-73. PubMed ID: 11229845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haematopoietic growth factors as supportive therapy in HIV-infected patients.
    Hermans P
    AIDS; 1995 Dec; 9 Suppl 2():S9-S14. PubMed ID: 8775801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of hematopoietic hormones in HIV infection and AIDS-related malignancies.
    Miles SA; Golde DW; Mitsuyasu RT
    Hematol Oncol Clin North Am; 1991 Apr; 5(2):267-80. PubMed ID: 2022593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical uses of hematopoietic growth hormones in HIV-related illnesses.
    Mitsuyasu RT
    AIDS Clin Rev; 1993-1994; ():189-212. PubMed ID: 7692940
    [No Abstract]   [Full Text] [Related]  

  • 6. Hematopoietic growth factors as adjuncts to antiretroviral therapy.
    Miles SA
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1073-80. PubMed ID: 1380256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
    Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.
    Jacobson JM; Lederman MM; Spritzler J; Valdez H; Tebas P; Skowron G; Wang R; Jackson JB; Fox L; Landay A; Gilbert MJ; O'Neil D; Bancroft L; Al-Harthi L; Jacobson MA; Merigan TC; Glesby MJ;
    J Infect Dis; 2003 Dec; 188(12):1804-14. PubMed ID: 14673758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic toxicity of zidovudine in HIV-infected patients.
    Brogan KL; Zell SC
    Am Fam Physician; 1990 May; 41(5):1521-8. PubMed ID: 1692180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
    Page AV; Liles WC
    Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate.
    Hofbauer GF; Baur T; Bonnet MC; Tartour E; Burg G; Berinstein NL; Dummer R
    Melanoma Res; 2008 Apr; 18(2):104-11. PubMed ID: 18337646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias.
    Miles SA; Lee K; Hutlin L; Zsebo KM; Mitsuyasu RT
    Blood; 1991 Dec; 78(12):3200-8. PubMed ID: 1720698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
    Kasper C; Zahner J; Sayer HG
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):497-502. PubMed ID: 12242514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune therapy: non-highly active antiretroviral therapy management of human immunodeficiency virus-infected patients.
    Mitsuyasu R
    J Infect Dis; 2002 May; 185 Suppl 2():S115-22. PubMed ID: 12001032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical application of recombinant erythropoietin in the HIV-infected patient.
    Glaspy JA; Chap L
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):945-59. PubMed ID: 7852217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mobilization of autologous peripheral blood stem cells by chemotherapy and recombinant granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF)].
    Cui X; Shao Y; Ren B; Tong Z; Ren X; Li L; Zhang Z; Zhang N; Dai R; Hao X
    Zhonghua Xue Ye Xue Za Zhi; 2000 May; 21(5):247-9. PubMed ID: 11876989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythropoietin treatment of anemia associated with human immunodeficiency virus infection].
    Moreno García M
    Med Clin (Barc); 1997 Feb; 108(7):266-71. PubMed ID: 9121196
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
    Wu HH; Talpaz M; Champlin RE; Pilat SR; Kurzrock R
    Cancer; 2003 Dec; 98(11):2410-9. PubMed ID: 14635076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Class I cytokines (interleukin-2-7, interleukin-9, interleukin-11, interleukin-12, interleukin-13, interleukin-15, granulocyte-macrophage colony-stimulating factor, granulocyte-colony stimulating factor, erythropoietin)].
    Yokota T
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():187-92. PubMed ID: 15861655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.